{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T22:08:57Z","timestamp":1774649337188,"version":"3.50.1"},"reference-count":141,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T00:00:00Z","timestamp":1602547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010667","name":"H2020 Industrial Leadership","doi-asserted-by":"publisher","award":["760928"],"award-info":[{"award-number":["760928"]}],"id":[{"id":"10.13039\/100010667","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDP\/50017\/2020+UIDB\/50017\/2020"],"award-info":[{"award-number":["UIDP\/50017\/2020+UIDB\/50017\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Materials"],"abstract":"<jats:p>The convergence of nanotechnology and biotechnology has led to substantial advancements in nano-biomaterials (NBMs) used in medical devices (MD) and advanced therapy medicinal products (ATMP). However, there are concerns that applications of NBMs for medical diagnostics, therapeutics and regenerative medicine could also pose health and\/or environmental risks since the current understanding of their safety is incomplete. A scientific strategy is therefore needed to assess all risks emerging along the life cycles of these products. To address this need, an overarching risk management framework (RMF) for NBMs used in MD and ATMP is presented in this paper, as a result of a collaborative effort of a team of experts within the EU Project BIORIMA and with relevant inputs from external stakeholders. The framework, in line with current regulatory requirements, is designed according to state-of-the-art approaches to risk assessment and management of both nanomaterials and biomaterials. The collection\/generation of data for NBMs safety assessment is based on innovative integrated approaches to testing and assessment (IATA). The framework can support stakeholders (e.g., manufacturers, regulators, consultants) in systematically assessing not only patient safety but also occupational (including healthcare workers) and environmental risks along the life cycle of MD and ATMP. The outputs of the framework enable the user to identify suitable safe(r)-by-design alternatives and\/or risk management measures and to compare the risks of NBMs to their (clinical) benefits, based on efficacy, quality and cost criteria, in order to inform robust risk management decision-making.<\/jats:p>","DOI":"10.3390\/ma13204532","type":"journal-article","created":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T08:59:22Z","timestamp":1602665962000},"page":"4532","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Risk Management Framework for Nano-Biomaterials Used in Medical Devices and Advanced Therapy Medicinal Products"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6335-0735","authenticated-orcid":false,"given":"Elisa","family":"Giubilato","sequence":"first","affiliation":[{"name":"Department of Environmental Sciences, Informatics and Statistics, University Ca\u2019 Foscari of Venice, Via Torino 155, 30172 Venice, Italy"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2565-1654","authenticated-orcid":false,"given":"Virginia","family":"Cazzagon","sequence":"additional","affiliation":[{"name":"Department of Environmental Sciences, Informatics and Statistics, University Ca\u2019 Foscari of Venice, Via Torino 155, 30172 Venice, Italy"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8137-3295","authenticated-orcid":false,"given":"M\u00f3nica J. B.","family":"Amorim","sequence":"additional","affiliation":[{"name":"Department of Biology and CESAM, University of Aveiro, 3810-193 Aveiro, Portugal"}]},{"given":"Magda","family":"Blosi","sequence":"additional","affiliation":[{"name":"Institute of Science and Technology for Ceramics, National Research Council of Italy (CNR-ISTEC), Via Granarolo 64, 48018 Faenza, Italy"}]},{"given":"Jacques","family":"Bouillard","sequence":"additional","affiliation":[{"name":"Institut National de l\u2019Environnement industriel et des Risques, Parc Technologique ALATA, 60550 Verneuil-en-Halatte, France"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9318-4272","authenticated-orcid":false,"given":"Hans","family":"Bouwmeester","sequence":"additional","affiliation":[{"name":"Division of Toxicology, Wageningen University, 6708 WE Wageningen, The Netherlands"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1407-6498","authenticated-orcid":false,"given":"Anna Luisa","family":"Costa","sequence":"additional","affiliation":[{"name":"Institute of Science and Technology for Ceramics, National Research Council of Italy (CNR-ISTEC), Via Granarolo 64, 48018 Faenza, Italy"}]},{"given":"Bengt","family":"Fadeel","sequence":"additional","affiliation":[{"name":"Division of Molecular Toxicology, Institute of Environmental Medicine, Karolinska Institutet, 171 77 Stockholm, Sweden"}]},{"given":"Teresa F.","family":"Fernandes","sequence":"additional","affiliation":[{"name":"Institute of Life and Earth Sciences, School of Energy, Geoscience, Infrastructure and Society, Heriot-Watt University, Edinburgh EH14 4AS, UK"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5437-5519","authenticated-orcid":false,"given":"Carlos","family":"Fito","sequence":"additional","affiliation":[{"name":"Instituto Tecnologico del Embalaje, Transporte y Logistica, 46980 Paterna-Valencia, Spain"}]},{"given":"Marina","family":"Hauser","sequence":"additional","affiliation":[{"name":"Empa, Swiss Federal Laboratories for Materials Science and Technology, Lerchenfeldstrasse 5, 9014 St. Gallen, Switzerland"}]},{"given":"Antonio","family":"Marcomini","sequence":"additional","affiliation":[{"name":"Department of Environmental Sciences, Informatics and Statistics, University Ca\u2019 Foscari of Venice, Via Torino 155, 30172 Venice, Italy"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5676-112X","authenticated-orcid":false,"given":"Bernd","family":"Nowack","sequence":"additional","affiliation":[{"name":"Empa, Swiss Federal Laboratories for Materials Science and Technology, Lerchenfeldstrasse 5, 9014 St. Gallen, Switzerland"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9434-9104","authenticated-orcid":false,"given":"Lisa","family":"Pizzol","sequence":"additional","affiliation":[{"name":"GreenDecision Srl, Via delle Industrie, 21\/8, 30175 Venice, Italy"}]},{"given":"Leagh","family":"Powell","sequence":"additional","affiliation":[{"name":"Institute of Biological Chemistry, Biophysics and Bioengineering, School of Engineering and Physical Sciences, Heriot-Watt University, Edinburgh EH14 4AS, UK"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4371-2214","authenticated-orcid":false,"given":"Adriele","family":"Prina-Mello","sequence":"additional","affiliation":[{"name":"Trinity Translational Medicine Institute, Trinity College, The University of Dublin, Dublin 8, Ireland"}]},{"given":"Haralambos","family":"Sarimveis","sequence":"additional","affiliation":[{"name":"School of Chemical Engineering, National Technical University of Athens, 15780 Athens, Greece"}]},{"given":"Janeck James","family":"Scott-Fordsmand","sequence":"additional","affiliation":[{"name":"Department of Bioscience, Aarhus University, 8600 Silkeborg, Denmark"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8032-8687","authenticated-orcid":false,"given":"Elena","family":"Semenzin","sequence":"additional","affiliation":[{"name":"Department of Environmental Sciences, Informatics and Statistics, University Ca\u2019 Foscari of Venice, Via Torino 155, 30172 Venice, Italy"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8035-5589","authenticated-orcid":false,"given":"Burkhard","family":"Stahlmecke","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Energie und Umwelttechnik e.V., 47229 Duisburg, Germany"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8346-7471","authenticated-orcid":false,"given":"Vicki","family":"Stone","sequence":"additional","affiliation":[{"name":"Institute of Biological Chemistry, Biophysics and Bioengineering, School of Engineering and Physical Sciences, Heriot-Watt University, Edinburgh EH14 4AS, UK"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0737-7911","authenticated-orcid":false,"given":"Alexis","family":"Vignes","sequence":"additional","affiliation":[{"name":"Institut National de l\u2019Environnement industriel et des Risques, Parc Technologique ALATA, 60550 Verneuil-en-Halatte, France"}]},{"given":"Terry","family":"Wilkins","sequence":"additional","affiliation":[{"name":"Nanomanufacturing Institute, School of Chemical and Process Engineering, University of Leeds, Leeds LS2 9JT, UK"}]},{"given":"Alex","family":"Zabeo","sequence":"additional","affiliation":[{"name":"GreenDecision Srl, Via delle Industrie, 21\/8, 30175 Venice, Italy"}]},{"given":"Lang","family":"Tran","sequence":"additional","affiliation":[{"name":"Institute of Occupational Medicine, Research Avenue North, Riccarton, Edinburgh EH14 4AP, UK"}]},{"given":"Danail","family":"Hristozov","sequence":"additional","affiliation":[{"name":"Department of Environmental Sciences, Informatics and Statistics, University Ca\u2019 Foscari of Venice, Via Torino 155, 30172 Venice, Italy"}]}],"member":"1968","published-online":{"date-parts":[[2020,10,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/adem.201080140","article-title":"Nanobiomaterials: State of the Art and Future Trends","volume":"13","author":"Yang","year":"2011","journal-title":"Adv. Eng. Mater."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Singh, T.G., Dhiman, S., Jindal, M., Sandhu, I.S., and Chitkara, M. (2016). Nanobiomaterials: Applications in Biomedicine and Biotechnology. Fabrication and Self-Assembly of Nanobiomaterials: Applications of Nanobiomaterials, William Andrew Publishing.","DOI":"10.1016\/B978-0-323-41533-0.00013-1"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Genchi, G.G., Marino, A., Grillone, A., Pezzini, I., and Ciofani, G. (2017). Smart Nanobiomaterials: Remote Control of Cellular Functions: The Role of Smart Nanomaterials in the Medicine of the Future. Adv. Healthc. Mater., 6.","DOI":"10.1002\/adhm.201700002"},{"key":"ref_4","first-page":"985","article-title":"Potential Biomedical Applications of Metallic Nanobiomaterials: A Review","volume":"8","author":"Shivaramakrishnan","year":"2017","journal-title":"Int. J. Pharm. Sci. Res."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Li, X., Lee, S.C., Zhang, S., and Akasaka, T. (2015). Biocompatibility and Toxicity of Nanobiomaterials 2014. J. Nanomater.","DOI":"10.1155\/2015\/259264"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1162\/GLEP_a_00096","article-title":"Regulating Nanotechnologies: Risk, Uncertainty and the Global Governance Gap","volume":"12","author":"Falkner","year":"2012","journal-title":"Glob. Environ. Polit."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Linkov, I., and Steevens, J. (2008). Nanomaterials: Risks and Benefits, Springer Science & Business Media.","DOI":"10.1007\/978-1-4020-9491-0"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.nano.2008.01.001","article-title":"Nanotoxicology and Nanomedicine: Making Hard Decisions","volume":"4","author":"Linkov","year":"2008","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11569-008-0027-x","article-title":"Regulating Nanotechnologies: Risk Management Models and Nanomedicine","volume":"2","author":"Schummer","year":"2008","journal-title":"Nanoethics"},{"key":"ref_10","unstructured":"Halamoda-Kenzaoui, B., Box, H., van Elk, M., Gaitan, S., Geertsma, R.E., Gainza Lafuente, E., Owen, A., Del Pozo, A., Roesslein, M., and Bremer-Hoffmann, S. (2019). Anticipation of Regulatory Needs for Nanotechnology\u2014Enabled Health Products, Publications Office of the European Union. The REFINE White Paper."},{"key":"ref_11","unstructured":"(2020, September 17). BIORIMA|Risk Management of Biomaterials. Available online: https:\/\/www.biorima.eu\/."},{"key":"ref_12","unstructured":"European Commission (EC) (2006). Regulation (EC) No 1907\/2006 of the European Parliament and of the Council of 18 December 2006 Concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), Establishing a European Chemicals Agency, Amending Directive 1999\/45\/EC and Repealing Council Regulation (EEC) No 793\/93 and Commission Regulation (EC) No 1488\/94 as well as Council Directive 76\/769\/EEC and Commission Directives 91\/155\/EEC, 93\/67\/EEC, 93\/105\/EC and 2000\/21\/EC."},{"key":"ref_13","unstructured":"European Commission (EC) (2000). Directive No. 1999\/92\/EC, of 16 December 1999, on Minimum Requirements for Improving the Safety and Health Protection of Workers Potentially at Risk from Explosive Atmospheres."},{"key":"ref_14","unstructured":"European Medicines Agency (EMA) (2007). Report of the CHMP Working Group on Benifit-Risk Assessment Models and Methods."},{"key":"ref_15","unstructured":"European Commission (EC) (2007). Regulation (EC) No 1394\/2007 of the European Parliament and of the Council of the 13 November 2007 on Advanced Therapy Medicinal Products and Amending Directive 2001\/83\/EC and Regulation (EC) No 726\/2004."},{"key":"ref_16","unstructured":"European Commission (EC) (2017). Regulation (EU) 2017\/745 of the European Parliament and of the Council of 5 April 2017 on Medical Devices, Amending Directive 2001\/83\/EC, Regulation (EC) No 178\/2002 and Regulation (EC) No 1223\/2009 and Repealing Council Directives 90\/385\/EEC and 93\/42\/EEC."},{"key":"ref_17","unstructured":"European Commission (EC) (2009). Commission Directive 2009\/120\/EC of 14 September 2009 Amending Directive 2001\/83\/EC of the European Parliament and of the Council on the Community code Relating to Medicinal Products for Human Use as Regards Advanced Therapy Medicinal Products."},{"key":"ref_18","unstructured":"International Organization for Standardization (ISO) (2019). ISO 14971:2019 Medical Devices\u2014Application of Risk Management to Medical Devices, ISO."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1517\/14740330903362422","article-title":"Exploratory Safety Pharmacology: A New Safety Paradigm to de-Risk Drug Candidates Prior to Selection for Regulatory Science Investigations","volume":"8","author":"Cavero","year":"2009","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.31887\/DCNS.2011.13.2\/fcurtin","article-title":"Assessing the Benefit: Risk Ratio of a Drug--Randomized and Naturalistic Evidence","volume":"13","author":"Curtin","year":"2011","journal-title":"Dialogues Clin. Neurosci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3389\/fbioe.2019.00261","article-title":"Hazard Assessment of Polymeric Nanobiomaterials for Drug Delivery: What Can We Learn From Literature So Far","volume":"7","author":"Jesus","year":"2019","journal-title":"Front. Bioeng. Biotechnol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12302-020-00369-8","article-title":"Environmental Hazard Testing of Nanobiomaterials","volume":"32","author":"Amorim","year":"2020","journal-title":"Environ. Sci. Eur."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3762\/bjnano.11.44","article-title":"Identification of Physicochemical Properties That Modulate Nanoparticle Aggregation in Blood","volume":"11","author":"Soddu","year":"2020","journal-title":"Beilstein J. Nanotechnol."},{"key":"ref_24","first-page":"1201","article-title":"Colloidal Characterization of CuO Nanoparticles in Biological and Environmental Media","volume":"4","author":"Ortelli","year":"2017","journal-title":"Environ. Ment. Sci. Nano"},{"key":"ref_25","unstructured":"Capco, D., and Chen, Y. (2014). Nanomaterials: Impact on Cells and Cell Organelles, Nanomateri, Springer."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1743-8977-11-9","article-title":"ITS-NANO\u2014Prioritising Nanosafety Research to Develop a Stakeholder Driven Intelligent Testing Strategy","volume":"11","author":"Stone","year":"2014","journal-title":"Part. Fibre Toxicol."},{"key":"ref_27","unstructured":"Organisation for Economic Co-operation and Development (OECD) (2016). Guidance Document on the Reporting of Defined Approaches to Be Used within Integrated Approaches to Testing and Assessment."},{"key":"ref_28","unstructured":"(2020, September 17). Integrated Approaches to Testing and Assessment (IATA)\u2014OECD. Available online: http:\/\/www.oecd.org\/chemicalsafety\/risk-assessment\/iata-integrated-approaches-to-testing-and-assessment.htm."},{"key":"ref_29","unstructured":"(2020, September 17). Home|Gracious. Available online: https:\/\/www.h2020gracious.eu\/."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejphar.2015.03.040","article-title":"The Multifactorial Role of the 3Rs in Shifting the Harm-Benefit Analysis in Animal Models of Disease","volume":"759","author":"Graham","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"ref_31","unstructured":"European Comission (EC) (2018). Commission Regulation (EU) 2018\/1881 of 3 December 2018 Amending Regulation (EC) No 1907\/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) as Regards Annexes I, III, VI, VII, VIII, IX, X, XI, and XII to Address Nanoforms of Substances."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"van Leeuwen, C.J., and Vermeire, T.G. (2007). Risk Assessment of Chemicals: An Introduction, Springer Science & Business Media. [2nd ed.].","DOI":"10.1007\/978-1-4020-6102-8"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/08958370902942608","article-title":"Physico-Chemical Characterization in the Light of Toxicological Effects","volume":"21","author":"Potthoff","year":"2009","journal-title":"Inhal. Toxicol."},{"key":"ref_34","unstructured":"European Chemicals Agency (ECHA) (2016). Guidance on Information Requirements and Chemical Safety AssessmentPart D: Framework for Exposure Assessment."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.impact.2017.09.002","article-title":"Progress towards Standardized and Validated Characterizations for Measuring Physicochemical Properties of Manufactured Nanomaterials Relevant to Nano Health and Safety Risks","volume":"9","author":"Gao","year":"2018","journal-title":"NanoImpact"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1021\/nn505015e","article-title":"Review of Nanomaterials in Dentistry: Interactions with the Oral","volume":"9","author":"Besinis","year":"2015","journal-title":"ACS Nano"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.actbio.2013.09.044","article-title":"Nanoparticle Release from Dental Composites","volume":"10","author":"Hellack","year":"2014","journal-title":"Acta Biomater."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Wohlleben, W., Kuhlbusch, T.A.J., Schnekenburger, J., and Lehr, C.M. (2015). Safety of Nanomaterials along Their Lifecycle. Release, Exposure, and Human Hazards, Taylor & Francis Group.","DOI":"10.1201\/b17774"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1080\/15459624.2016.1167278","article-title":"Refinement of the Nanoparticle Emission Assessment Technique into the Nanomaterial Exposure Assessment Technique (NEAT 2.0)","volume":"13","author":"Eastlake","year":"2016","journal-title":"J. Occup. Environ. Hyg."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Ramachandran, G., Park, J.Y., and Raynor, P.C. (2011). Assessing Exposures to Nanomaterials in the Occupational Environment, Elsevier.","DOI":"10.1016\/B978-1-4377-7863-2.00002-9"},{"key":"ref_41","unstructured":"Organisation for Economic Co-operation and Development (OECD) (2015). Harmonized Tiered Approach to Measure and Assess the Potential Exposure to Airborne Emissions of Engineered Nano-Objects and Their Agglomerates and Aggregates at Workplaces, ENV\/JM\/MONO1."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.impact.2017.11.003","article-title":"Nanomaterial Exposures for Worker, Consumer and the General Public","volume":"10","author":"Kuhlbusch","year":"2018","journal-title":"NanoImpact"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/annweh\/wxz027","article-title":"Calibration of the Dermal Advanced REACH Tool (DART) Mechanistic Model","volume":"63","author":"McNally","year":"2019","journal-title":"Ann. Work Expo. Health"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/risa.12286","article-title":"Sensitivity Analysis, Dominant Factors, and Robustness of the ECETOC TRA v3, Stoffenmanager 4.5, and ART 1.5 Occupational Exposure Models","volume":"35","author":"Riedmann","year":"2015","journal-title":"Risk Anal."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Spinazz\u00e8, A., Borghi, F., Campagnolo, D., Rovelli, S., Keller, M., Fanti, G., Cattaneo, A., and Cavallo, D.M. (2019). How to Obtain a Reliable Estimate of Occupational Exposure? Review and Discussion of Models\u2019 Reliability. Int. J. Environ. Res. Public Health, 16.","DOI":"10.3390\/ijerph16152764"},{"key":"ref_46","first-page":"1000","article-title":"The relationship between inadvertent ingestion and dermal exposure pathways: A new integrated conceptual model and a database of dermal and oral transfer efficiencies","volume":"56","author":"Semple","year":"2012","journal-title":"Ann Occup Hyg."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s40262-019-00741-9","article-title":"Physiologically Based Pharmacokinetic Modelling for First-In-Human Predictions: An Updated Model Building Strategy Illustrated with Challenging Industry Case Studies","volume":"58","author":"Miller","year":"2019","journal-title":"Clin. Pharmacokinet."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1208\/s12248-016-0010-3","article-title":"Physiologically Based Pharmacokinetic (PBPK) Modeling of Pharmaceutical Nanoparticles","volume":"19","author":"Li","year":"2017","journal-title":"AAPS J."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3109\/17435390.2014.991431","article-title":"Towards an Alternative Testing Strategy for Nanomaterials Used in Nanomedicine: Lessons from NanoTEST","volume":"5390","author":"Dusinska","year":"2015","journal-title":"Nanotoxicology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.impact.2017.08.002","article-title":"In Vitro Approaches to Assess the Hazard of Nanomaterials","volume":"8","author":"Drasler","year":"2017","journal-title":"NanoImpact"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/s41565-018-0185-0","article-title":"Advanced Tools for the Safety Assessment of Nanomaterials","volume":"13","author":"Fadeel","year":"2018","journal-title":"Nat. Nanotechnol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2217\/nnm.09.40","article-title":"The Status of in Vitro Toxicity Studies in the Risk Assessment of Nanomaterials","volume":"4","author":"Park","year":"2009","journal-title":"Nanomedicine"},{"key":"ref_53","unstructured":"Organisation for Economic Co-operation and Development (OECD) (2018). Oecd Series on Principles of Good Laboratory Practice and Compliance Monitoring Number 19, Advisory Document of the Working Group on Good Laboratory Practice on the Management, Characterisation and Use of Test Items. ENV\/JM\/MONO (2018)6."},{"key":"ref_54","first-page":"1","article-title":"Adverse Outcome Pathways as a Tool for the Design of Testing Strategies to Support the Safety Assessment of Emerging Advanced Materials at the Nanoscale","volume":"4","author":"Halappanavar","year":"2020","journal-title":"Part. Fibre Toxicol."},{"key":"ref_55","unstructured":"Lynch, I.E. (2017). Compendium of Projects in the NanoSafetyCluster, NanoSafety Cluster. Available online: https:\/\/www.nanosafetycluster.eu\/outputs\/nsc-compendium\/."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3109\/17435390.2013.829590","article-title":"Toxicity Screenings of Nanomaterials: Challenges Due to Interference with Assay Processes and Components of Classic in Vitro Tests","volume":"9","author":"Guadagnini","year":"2013","journal-title":"Nanotoxicology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00204-017-2106-7","article-title":"Microscopy\u2014Based High\u2014Throughput Assays Enable Multi\u2014Parametric Analysis to Assess Adverse Effects of Nanomaterials in Various Cell Lines","volume":"92","author":"Hansjosten","year":"2018","journal-title":"Arch. Toxicol."},{"key":"ref_58","unstructured":"Fadeel, B. (2018). Nanotoxicology. State-of-the-Art and Future Research Needs, Institute of Environmental Medicine, Karolinska Institute. IMM Report 1\/2018."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/s41565-018-0246-4","article-title":"Minimum Information Reporting in Bio-Nano Experimental Literature","volume":"13","author":"Faria","year":"2018","journal-title":"Nat. Nanotechnol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1900133","DOI":"10.1002\/advs.201900133","article-title":"Immunotoxicity Considerations for Next Generation Cancer Nanomedicines","volume":"6","author":"Hannon","year":"2019","journal-title":"Adv. Sci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1021\/ja107583h","article-title":"Physical-Chemical Aspects of Protein Corona: Relevance to in Vitro and in Vivo Biological Impacts of Nanoparticles","volume":"133","author":"Monopoli","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1021\/acs.biomac.6b01545","article-title":"Cell-Conditioned Protein Coronas on Engineered Particles Influence Immune Responses","volume":"18","author":"Dai","year":"2017","journal-title":"Biomacromolecules"},{"key":"ref_63","unstructured":"European Medicines Agency (EMA) (2018). Guideline on the Environmental Risk Assessment of Medicinal Products for Human Use."},{"key":"ref_64","unstructured":"Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) (2015). Guidance on the Determination of Potential Health Effects of Nanomaterials Used in Medical Devices."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1021\/acs.est.5b05828","article-title":"Dynamic Probabilistic Modeling of Environmental Emissions of Engineered Nanomaterials","volume":"50","author":"Sun","year":"2016","journal-title":"Environ. Sci. Technol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1002\/etc.3904","article-title":"Long-Term Effects of Sulfidized Silver Nanoparticles in Sewage Sludge on Soil Microflora","volume":"36","author":"Kraas","year":"2017","journal-title":"Environ. Toxicol. Chem."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10856-018-6063-3","article-title":"Environmental Fate and Effect of Biodegradable Electro-Spun Scaffolds (Biomaterial)\u2014A Case Study","volume":"29","author":"Irizar","year":"2018","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.envpol.2015.08.048","article-title":"Effect Assessment of Engineered Nanoparticles in Solid Media\u2014Current Insight and the Way Forward","volume":"218","author":"Amorim","year":"2016","journal-title":"Environ. Pollut."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-08911-0","article-title":"Multigenerational Effects of Copper Nanomaterials (CuONMs) Are Different of Those of CuCl2: Exposure in the Soil Invertebrate Enchytraeus Crypticus","volume":"7","author":"Bicho","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jhazmat.2016.07.040","article-title":"Effects of Ag Nanomaterials (NM300K) and Ag Salt (AgNO3) Can Be Discriminated in a Full Life Cycle Long Term Test with Enchytraeus Crypticus","volume":"318","author":"Bicho","year":"2016","journal-title":"J. Hazard. Mater."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-01507-8","article-title":"Shorter Lifetime of a Soil Invertebrate Species When Exposed to Copper Oxide Nanoparticles in a Full Lifespan Exposure Test","volume":"7","author":"Goncalves","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.1021\/acs.est.8b00535","article-title":"Interactions of Soil Species Exposed to CuO NMs Are Different from Cu Salt: A Multispecies Test","volume":"52","author":"Mendes","year":"2018","journal-title":"Environ. Sci. Technol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/17435390.2018.1446559","article-title":"High-Throughput Tool to Discriminate Effects of NMs (Cu-NPs, Cu-Nanowires, CuNO3, and Cu Salt Aged): Transcriptomics in Enchytraeus Crypticus","volume":"12","author":"Gomes","year":"2018","journal-title":"Nanotoxicology"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1080\/17435390.2018.1481237","article-title":"The Enchytraeus Crypticus Stress Metabolome\u2013CuO NM Case Study","volume":"12","author":"Maria","year":"2018","journal-title":"Nanotoxicology"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Europeand Food Safety Authority, Aguilera, J., Aguilera-Gomez, M., Barrucci, F., Cocconcelli, P.S., Davies, H., Denslow, N., Lou Dorne, J., Grohmann, L., and Herman, L. (2018). EFSA Scientific Colloquium 24\u2014omics in Risk Assessment: State of the Art and next Steps. EFSA Support. Publ., 15, 1512.","DOI":"10.2903\/sp.efsa.2018.EN-1512"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1080\/17435390.2016.1229517","article-title":"Regulatory Ecotoxicity Testing of Nanomaterials\u2014Proposed Modifications of OECD Test Guidelines Based on Laboratory Experience with Silver and Titanium Dioxide Nanoparticles","volume":"10","author":"Baun","year":"2016","journal-title":"Nanotoxicology"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1021\/acs.est.7b04122","article-title":"Environmental Impacts by Fragments Released from Nanoenabled Products: A Multiassay, Multimaterial Exploration by the SUN Approach","volume":"52","author":"Amorim","year":"2018","journal-title":"Environ. Sci. Technol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.nantod.2014.07.001","article-title":"A Unified Framework for Nanosafety Is Needed","volume":"9","author":"Tran","year":"2014","journal-title":"Nano Today"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Scott-Fordsmand, J.J., Peijnenburg, W.J.G.M., Semenzin, E., Nowack, B., Hunt, N., Hristozov, D., Marcomini, A., Irfan, M.A., Jim\u00e9nez, A.S., and Landsiedel, R. (2017). Environmental Risk Assessment Strategy for Nanomaterials. Int. J. Environ. Res. Public Health, 14.","DOI":"10.3390\/ijerph14101251"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1002\/etc.3103","article-title":"Species Sensitivity Weighted Distribution for Ecological Risk Assessment of Engineered Nanomaterials: The n-TiO2 Case Study","volume":"34","author":"Semenzin","year":"2015","journal-title":"Environ. Toxicol. Chem."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.proeng.2015.01.284","article-title":"Structure-Activity Relationship Models for Hazard Assessment and Risk Management of Engineered Nanomaterials","volume":"102","author":"Oksel","year":"2015","journal-title":"Procedia Eng."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.yrtph.2017.12.008","article-title":"Implementing the DF4 in a Robust Model, Allowing for Enhanced Comparison, Prioritisation and Grouping of Nanomaterials","volume":"92","author":"Amorim","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"ref_83","first-page":"1","article-title":"Nanosilver Pathophysiology in Earthworms: Transcriptional Profiling of Secretory Proteins and the Implication for the Protein Corona","volume":"5390","author":"Hayashi","year":"2015","journal-title":"Nanotoxicology"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1039\/C8EN01378K","article-title":"Strategies for Robust and Accurate Experimental Approaches to Quantify Nanomaterial Bioaccumulation across a Broad Range of Organisms","volume":"6","author":"Petersen","year":"2019","journal-title":"Environ. Sci. Nano"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"15756","DOI":"10.3390\/ijerph121215020","article-title":"Detection of Engineered Copper Nanoparticles in Soil Using Single Particle ICP-MS","volume":"12","author":"Navratilova","year":"2015","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1071\/EN14037","article-title":"Current Status and Future Direction for Examining Engineered Nanoparticles in Natural Systems","volume":"11","author":"Lowry","year":"2014","journal-title":"Environ. Chem."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.impact.2017.06.005","article-title":"Evaluation of Environmental Exposure Models for Engineered Nanomaterials in a Regulatory Context","volume":"8","author":"Nowack","year":"2017","journal-title":"NanoImpact"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.envsoft.2009.08.011","article-title":"Probabilistic Material Flow Modeling for Assessing the Environmental Exposure to Compounds: Methodology and an Application to Engineered Nano-TiO2 Particles","volume":"25","author":"Gottschalk","year":"2010","journal-title":"Environ. Model. Softw."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.envpol.2013.10.004","article-title":"Comprehensive Probabilistic Modelling of Environmental Emissions of Engineered Nanomaterials","volume":"185","author":"Sun","year":"2014","journal-title":"Environ. Pollut."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1021\/acs.est.6b05702","article-title":"Envisioning Nano Release Dynamics in a Changing World: Using Dynamic Probabilistic Modeling to Assess Future Environmental Emissions of Engineered Nanomaterials","volume":"51","author":"Sun","year":"2017","journal-title":"Environ. Sci. Technol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/etc.4080","article-title":"Environmental Risk Assessment of Engineered Nano-SiO2, Nano Iron Oxides, Nano-CeO2, Nano-Al2O3, and Quantum Dots","volume":"37","author":"Wang","year":"2018","journal-title":"Environ. Toxicol. Chem."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.scitotenv.2015.12.100","article-title":"Probabilistic Modeling of the Flows and Environmental Risks of Nano-Silica","volume":"545\u2013546","author":"Wang","year":"2016","journal-title":"Sci. Total Environ."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.envpol.2018.07.108","article-title":"Considering the Forms of Released Engineered Nanomaterials in Probabilistic Material Flow Analysis","volume":"243","author":"Adam","year":"2018","journal-title":"Environ. Pollut."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-015-0150-0","article-title":"Probabilistic Modelling of Prospective Environmental Concentrations of Gold Nanoparticles from Medical Applications as a Basis for Risk Assessment","volume":"13","author":"Mahapatra","year":"2015","journal-title":"J. Nanobiotechnol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1530-9290.2011.00400.x","article-title":"Impacts of a Silver-Coated Future: Particle Flow Analysis of Silver Nanoparticles","volume":"15","author":"Arvidsson","year":"2011","journal-title":"J. Ind. Ecol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"5726","DOI":"10.1021\/es500548h","article-title":"Multimedia Modeling of Engineered Nanoparticles with SimpleBox4nano: Model Definition and Evaluation","volume":"48","author":"Meesters","year":"2014","journal-title":"Environ. Sci. Technol."},{"key":"ref_97","unstructured":"Liu, H.H., and Cohen, Y. (2012). Multimedia Environmental Distribution of Nanomaterials (MendNano). Technical Proceedings of the 2012 NSTI Nanotechnology Conference and Expo, CRC Press."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1039\/C9EN00448C","article-title":"Harmonizing across Environmental Nanomaterial Testing Media for Increased Comparability of Nanomaterial Datasets","volume":"7","author":"Geitner","year":"2020","journal-title":"Environ. Sci. Nano"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.scitotenv.2015.06.100","article-title":"A Functional Assay-Based Strategy for Nanomaterial Risk Forecasting","volume":"536","author":"Hendren","year":"2015","journal-title":"Sci. Total Environ."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-019-0489-8","article-title":"Environmental Hazard Assessment for Polymeric and Inorganic Nanobiomaterials Used in Drug Delivery","volume":"17","author":"Hauser","year":"2019","journal-title":"J. Nanobiotechnol."},{"key":"ref_101","unstructured":"European Committee for Standardization (CEN) (2018). CEN TS 17274:2018: Nanotechnologies\u2014Guidelines for Determining Protocols for the Explosivity and Flammability of Powders Containing Nano-Objects (for Transport, Handling and Storage)."},{"key":"ref_102","unstructured":"National Institute for Occupational Safety and Health (NIOSH) (2013). Current Strategies for Engineering Controls in Nanomaterial Production and Downstream Handling Processes. Publication No. 2014\u2013102."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3109\/17435390.2013.796534","article-title":"Principal Component and Causal Analysis of Structural and Acute in Vitro Toxicity Data for Nanoparticles","volume":"8","author":"Wang","year":"2014","journal-title":"Nanotoxicology"},{"key":"ref_104","unstructured":"Murphy, F., McAlea, E.M., and Mullins, M. (2016). Applying Safety by Molecular Design Concepts to Nanomaterials Risk Management. Managing Risk in Nanotechnology: Topics in Governance, Assurance and Transfer, Springer International Publishing."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11051-016-3412-3","article-title":"Extrapolated Long-Term Stability of Titanium Dioxide Nanoparticles and Multi-Walled Carbon Nanotubes in Artificial Freshwater","volume":"18","author":"Brunelli","year":"2016","journal-title":"J. Nanopart. Res."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1002\/smll.201600597","article-title":"An Experimental and Computational Approach to the Development of ZnO Nanoparticles That Are Safe by Design","volume":"12","author":"Le","year":"2016","journal-title":"Small"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/17435390.2017.1299891","article-title":"What Can Nanosafety Learn from Drug Development? The Feasibility of \u201cSafety by Design\u201d","volume":"11","author":"Hjorth","year":"2017","journal-title":"Nanotoxicology"},{"key":"ref_108","unstructured":"Gottardo, S., Crutzen, H., and Jantunen, P. (2017). NANoREG Framework for the Safety Assessment of Nanomaterials, JRC Science for Policy Report."},{"key":"ref_109","unstructured":"Joint EASAC-JRC Report (2011). Impact of Engineered Nanomaterials on Health: Considerations for Benefit-Risk Assessment."},{"key":"ref_110","unstructured":"Besson, J.P., King, P.W.B., Wilkins, T.A., McIvor, M.C., and Everall, N.J. (1996). European Patent Application EP 0 767 222 A2, Calcination of Titanium Dioxide."},{"key":"ref_111","unstructured":"U.S. Food and Drug Administration (FDA) (2004). Guidance for Industry, PAT-A Framework for Innovative Pharmaceutical Development, Manufacturing and Quality Assurance."},{"key":"ref_112","unstructured":"Brenderlberger, G. (2003). New PAT (Process Analytical Technology) Draft Guidance from FDA."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.cep.2018.09.022","article-title":"Process Intensification in Biologics Manufacturing","volume":"133","author":"Strube","year":"2018","journal-title":"Chem. Eng. Process. Process Intensif."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Babi, D.K., Cruz, M.S., and Gni, R. (2016). Fundaments of Process Intensification: A Process Systems Engineering View. Process Intensification in Chemical Engineering: Design Optimization and Control, Springer.","DOI":"10.1007\/978-3-319-28392-0_2"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"636","DOI":"10.3109\/17435390.2014.952698","article-title":"Nano(Q)SAR: Challenges, Pitfalls and Perspectives","volume":"9","author":"Tantra","year":"2015","journal-title":"Nanotoxicology"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3109\/17435390.2016.1161857","article-title":"Accurate and interpretable nanoSAR models from genetic programming-based decision tree construction approaches","volume":"10","author":"Oksel","year":"2016","journal-title":"Nanotoxicology"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17435390.2017.1415388","article-title":"Decision Tree Models to Classify Nanomaterials According to the DF4nanoGrouping Scheme","volume":"12","author":"Gajewicz","year":"2018","journal-title":"Nanotoxicology"},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Vazquez-Vazquez, F.C., Chanes-Cuevas, O.A., Masuoka, D., Alatorre, J.A., Chavarria-Bola\u00f1os, D., Vega-Baudrit, J.R., Serrano-Bello, J., and Alvarez-Perez, M.A. (2019). Biocompatibility of Developing 3D-Printed Tubular Scaffold Coated with Nanofibers for Bone Applications. J. Nanomater.","DOI":"10.1155\/2019\/6105818"},{"key":"ref_119","unstructured":"European Medicines Agency (EMA) (2015). Reflection Paper on the Data Requirements for Intravenous Iron-Based Nano-Colloidal Products Developed with Reference to an Innovator Medicinal Product."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.crhy.2011.06.001","article-title":"Nanomedicine, Nanotechnology in Medicine","volume":"12","author":"Boisseau","year":"2011","journal-title":"Comptes Rendus Phys."},{"key":"ref_121","unstructured":"European Medicines Agency (EMA) (2010). European Medicines Agency Benefit-Risk Methodology Project- Description of the Current Practice of Benefit-Risk Assessment for Cetralised Procedure Products in the EU Regulatory Network\u2014Summary of Original Report. Reproduction, 44, 2\u20134."},{"key":"ref_122","unstructured":"Hughes, D., Mt-Isa, S., Chan, E., Downey, G., Hallgreen, C.E., Hockley, K.S., Juhaeri, J., Lieftucht, A., Metcalfe, M.A., and Noel, R.A. (2020, September 30). IMI-PROTECT Benefit-Risk Group Recommendations Report. Recommendations for the Methodology and Visualisation Techniques to Be Used in the Assessment of Benefit and Risk of Medicines. Available online: http:\/\/www.imi-protect.eu\/documents\/HughesetalRecommendationsforthemethodologyandvisualisationtechniquestobeusedintheassessmento.pdf."},{"key":"ref_123","unstructured":"European Medicines Agency (EMA) (2011). Benefit-Risk Methodology Project\u2014Work Package 2 Report: Applicability of Current Tools and Processes for Regulatory Benefit-Risk Assessment."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/clpt.2010.291","article-title":"Development of a Framework for Enhancing the Transparency, Reproducibility and Communication of the Benefit-Risk Balance of Medicines","volume":"89","author":"Coplan","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_125","unstructured":"European Medicines Agency (EMA) (2008). Reflection Paper on Benefit-Risk Assessment Methods in the Context of the Evaluation of Marketing Authorisation Applications of Medicinal Products for Human Use."},{"key":"ref_126","unstructured":"U.S. Food and Drug Administration (FDA) (2018). Benefit-Risk Assessment in Drug Regulatory Decision-Making."},{"key":"ref_127","unstructured":"European Medicines Agency (EMA) (2008). Guideline on Safety and Efficacy Follow-Up\u2014Risk Management of Advanced Therapy Medicinal Products."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"e5644","DOI":"10.1590\/1414-431x20165644","article-title":"Non-Clinical Studies Required for New Drug Development\u2014Part I: Early in Silico and in Vitro Studies, New Target Discovery and Validation, Proof of Principles and Robustness of Animal Studies","volume":"49","author":"Andrade","year":"2016","journal-title":"Braz. J. Med. Biol. Res."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Sashegyi, A., Felli, J., and Noel, R. (2014). Benefit-Risk Assessment in Pharmaceutical Research and Development, CRC Press, Taylor and Francis Group.","DOI":"10.1201\/b16070"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/pds.4859","article-title":"EU Postmarket Surveillance Plans for Medical Devices","volume":"28","author":"Pane","year":"2019","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ddtec.2011.04.002","article-title":"Weighing Benefit-Risk of Medicines: Concepts and Approaches","volume":"8","author":"Tzoulaki","year":"2011","journal-title":"Drug Discov. Today Technol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1177\/2168479017696260","article-title":"The Benefit-Risk Assessment of Medicines","volume":"51","author":"McAuslane","year":"2017","journal-title":"Ther. Innov. Regul. Sci."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3389\/fphar.2015.00099","article-title":"A Practical Approach to Communicating Benefit-Risk Decisions of Medicines to Stakeholders","volume":"6","author":"Leong","year":"2015","journal-title":"Front. Pharmacol."},{"key":"ref_134","unstructured":"International Organization for Standardization (ISO) (2015). ISO 9001:2015\u2014Qality Management Systems-Requirements, ISO."},{"key":"ref_135","unstructured":"International Organization for Standardization (ISO) (2016). ISO 13485:2016 Medical Devices-Quality Management Systems, ISO."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.microc.2017.04.018","article-title":"Quality Aspects for Medical Devices, Quality System and Certification Process","volume":"136","author":"Geremia","year":"2018","journal-title":"Microchem. J."},{"key":"ref_137","unstructured":"International Organization for Standardization (ISO) (2007). ISO 14971:2007 Medical Devices-Application of Risk Management to Medical Devices, ISO."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"15007","DOI":"10.3390\/ijerph121214961","article-title":"The MARINA Risk Assessment Strategy: A Flexible Strategy for Efficient Information Collection and Risk Assessment of Nanomaterials","volume":"12","author":"Bos","year":"2015","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1289\/ehp.121-a220","article-title":"Nanosilver: Weighling the Risks and Benefits","volume":"121","author":"Seltenrich","year":"2013","journal-title":"Environ. Health Perspect."},{"key":"ref_140","unstructured":"Organisation for Economic Co-operation and Development (OECD) (2019). Physical-Chemical Decision Framework to Inform Decisions for Risk Assessment of Manufactured Nanomaterials."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jval.2016.04.006","article-title":"Patient-Focused Benefit-Risk Analysis to Inform Regulatory Decisions: The European Union Perspective","volume":"19","author":"Juhnke","year":"2016","journal-title":"Value Health"}],"container-title":["Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1996-1944\/13\/20\/4532\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:20:15Z","timestamp":1760178015000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1996-1944\/13\/20\/4532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,13]]},"references-count":141,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2020,10]]}},"alternative-id":["ma13204532"],"URL":"https:\/\/doi.org\/10.3390\/ma13204532","relation":{},"ISSN":["1996-1944"],"issn-type":[{"value":"1996-1944","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,13]]}}}